1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effects of hepatocyte growth factor on porcine mammary cell growth and senescence

      research-article
      a , b , a , c , d , * ,
      BioMedicine
      China Medical University
      Primary, Mammary, Xenogeneic cell, Xenoantigen

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The porcine mammary glands share morphological and physiological similarities with human ones, making primary porcine mammary cells (PMC) suitable for biomedical research and a potential cellular therapeutic for breast cancer xenogeneic cell immunotherapy. Primary cells isolated from tissues remain the physiological functions of origin tissues but their self-renewal ability is restricted and cells acquire senescence during in vitro expansion. To overcome these drawbacks, here we sought to establish an approach to efficiently increase PMC’s in vitro growth. We studied the effects of the hepatocyte growth factor (HGF) to maintain the expansion capacity of porcine mammary cells and identify the possible mechanisms.

          Purpose

          HGF could allow for the increase in vitro proliferation capacity of primary epithelial cells isolated from tissue samples. To effectively produce cells for biomedical research and xenogeneic cell therapy, we planned to study the effects of HGF and its potential mechanisms of action to stimulate cell growth for PMC expansion.

          Methods

          After HGF treatment, the growth, cell cycle, senescence and the cell marker gene expression of PMCs were analyzed in standard 10% FBS and low serum 1% FBS containing medium.

          Results

          HGF significantly enhanced the cell proliferation by shifting the cell cycle population from G1 phase into S phase to increase cell division, reduced the senescent cells and reprogrammed gene expression profiles.

          Conclusion

          We demonstrated that HGF could maintain the expansion capacity of PMCs by increasing cell growth and anti-senescence capability, suggesting its potential application in optimizing the long-term culture of primary cells. Adding a specific growth factor such as HGF in culture allows enhanced expansion of heterogeneous cell populations from normal porcine mammary glandular tissues in vitro. We believe that this cell culture approach will efficiently provide cells for studying mammary cell function and supply cells for therapeutic uses.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

          Differentiated cells can be reprogrammed to an embryonic-like state by transfer of nuclear contents into oocytes or by fusion with embryonic stem (ES) cells. Little is known about factors that induce this reprogramming. Here, we demonstrate induction of pluripotent stem cells from mouse embryonic or adult fibroblasts by introducing four factors, Oct3/4, Sox2, c-Myc, and Klf4, under ES cell culture conditions. Unexpectedly, Nanog was dispensable. These cells, which we designated iPS (induced pluripotent stem) cells, exhibit the morphology and growth properties of ES cells and express ES cell marker genes. Subcutaneous transplantation of iPS cells into nude mice resulted in tumors containing a variety of tissues from all three germ layers. Following injection into blastocysts, iPS cells contributed to mouse embryonic development. These data demonstrate that pluripotent stem cells can be directly generated from fibroblast cultures by the addition of only a few defined factors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The senescence-associated secretory phenotype: the dark side of tumor suppression.

            Cellular senescence is a tumor-suppressive mechanism that permanently arrests cells at risk for malignant transformation. However, accumulating evidence shows that senescent cells can have deleterious effects on the tissue microenvironment. The most significant of these effects is the acquisition of a senescence-associated secretory phenotype (SASP) that turns senescent fibroblasts into proinflammatory cells that have the ability to promote tumor progression.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

              Cellular senescence is a stable cell cycle arrest that can be triggered in normal cells in response to various intrinsic and extrinsic stimuli, as well as developmental signals. Senescence is considered to be a highly dynamic, multi-step process, during which the properties of senescent cells continuously evolve and diversify in a context dependent manner. It is associated with multiple cellular and molecular changes and distinct phenotypic alterations, including a stable proliferation arrest unresponsive to mitogenic stimuli. Senescent cells remain viable, have alterations in metabolic activity and undergo dramatic changes in gene expression and develop a complex senescence-associated secretory phenotype. Cellular senescence can compromise tissue repair and regeneration, thereby contributing toward aging. Removal of senescent cells can attenuate age-related tissue dysfunction and extend health span. Senescence can also act as a potent anti-tumor mechanism, by preventing proliferation of potentially cancerous cells. It is a cellular program which acts as a double-edged sword, with both beneficial and detrimental effects on the health of the organism, and considered to be an example of evolutionary antagonistic pleiotropy. Activation of the p53/p21WAF1/CIP1 and p16INK4A/pRB tumor suppressor pathways play a central role in regulating senescence. Several other pathways have recently been implicated in mediating senescence and the senescent phenotype. Herein we review the molecular mechanisms that underlie cellular senescence and the senescence associated growth arrest with a particular focus on why cells stop dividing, the stability of the growth arrest, the hypersecretory phenotype and how the different pathways are all integrated.
                Bookmark

                Author and article information

                Journal
                Biomedicine (Taipei)
                Biomedicine (Taipei)
                BioMedicine
                China Medical University
                2211-8020
                2211-8039
                2023
                01 March 2023
                : 13
                : 1
                : 13-21
                Affiliations
                [a ]Department of Medicine, Urology Division, China Medical University and Hospital, Taichung, Taiwan
                [b ]Department of Medicine, Department of Surgery, College of Medicine, China Medical University and Hospital, Taichung, Taiwan
                [c ]Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
                [d ]eXCELL Biotherapeutics INC., Taichung, Taiwan
                Author notes
                [* ]Corresponding author at. Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan. E-mail address: chshyr@ 123456mail.cmu.edu.tw (C.-R. Shyr).
                Article
                bmed-13-01-013
                10.37796/2211-8039.1392
                10166252
                37168728
                f9464a46-2674-4752-8f5f-595242276d65
                © the Author(s)

                This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 15 September 2022
                : 15 October 2022
                : 18 October 2022
                Funding
                Funded by: NSC
                Award ID: 110-2314-B-039-026-MY3-
                Funded by: National Science and Technology Council, Taiwan and CMUH
                Award ID: DMR-111-212
                Award ID: DMR-CELL-1807
                Funded by: China Medical University Hospital, Taiwan
                This work was supported by the NSC grants (110-2314-B-039-026-MY3-), National Science and Technology Council, Taiwan and CMUH (DMR-111-212 and DMR-CELL-1807), China Medical University Hospital, Taiwan.
                Categories
                Original Article

                primary,mammary,xenogeneic cell,xenoantigen
                primary, mammary, xenogeneic cell, xenoantigen

                Comments

                Comment on this article